mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.5 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.5 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.5 |